RESUMO
Alzheimer's disease (AD) is the most frequent form of dementia and according to the most recent estimation it affects nearly 27 million people in the world. The onset of the disease is generally insidious. It is becoming increasingly evident that the underlying pathophysiological mechanisms are active long before the appearance of the clinical symptoms of the disease. In the current context, it is important to develop strategies to delay the onset of cognitive decline. Delaying the onset by 5 years would reduce the prevalence by half at term, and a delay of 10 years would reduce it by three-quarters. The effectiveness of currently suggested preventive approaches remains to be confirmed, but certain strategies could be applied straight away to at-risk subjects. We propose that a health-promoting memory consultation should be set up for elderly persons who have attended a specialized memory consultation and in whom the diagnosis of dementia and of AD in particular, has not been established by standardized tools. Through this consultation, they would be offered full multidimensional investigation of all aspects of their health status, follow-up could be organized, general practitioners in private practice could be made more conscious of this population and the elderly could be made more aware of the risk factors to which they are exposed. The development of an information policy for the elderly would meet a present need. In our reflection, we must take into account the question of how to give this preventive consultation its due place in the healthcare pathway of the elderly person in order to ensure coordinated follow-up with all the other health professionals involved. The principle of the health-promoting memory consultation is undergoing validation in a large French multicentre preventive trial in 1200 frail elderly persons aged 70 years followed for three years, the Multidomain Alzheimer Preventive Trial (MAPT).
Assuntos
Envelhecimento/psicologia , Demência/prevenção & controle , Serviços de Saúde para Idosos/organização & administração , Transtornos da Memória/prevenção & controle , Memória/fisiologia , Idoso , Idoso de 80 Anos ou mais , Instituições de Assistência Ambulatorial , Progressão da Doença , Feminino , Promoção da Saúde , Humanos , Masculino , Programas de Rastreamento , Transtornos da Memória/epidemiologia , Transtornos da Memória/fisiopatologia , Encaminhamento e Consulta , Fatores de RiscoRESUMO
Under the auspices of the French Society of Gerontology and Geriatrics, a multidisciplinary team including geriatritians, neurologists, epidemiologists, psychiatrists, pharmacologists and public health specialists developed a consensus on care for patients with severe dementia. They defined 21 recommendations for general practitioners, long-term care physicians and specialists based on knowledge available in 2005. At all stages of the disease, the objective of care is to improve as much as possible quality-of-life for the patient and his/her family, including a life project until the end of life. It is always possible to do something for these patients and their family: nutritional status, behavior disorders, and incapacities to deal with basic activities of daily life have to be taken in consideration. Resource allocation and proximity care have to be targeted. Research areas necessary to improve the care of patients with severe dementia has been selected.
Assuntos
Doença de Alzheimer/terapia , Consenso , Demência/terapia , Idoso , Doença de Alzheimer/diagnóstico , Transtornos Cognitivos/diagnóstico , Transtornos Cognitivos/terapia , Demência/diagnóstico , Diagnóstico Diferencial , Humanos , Testes Neuropsicológicos , Índice de Gravidade de DoençaRESUMO
Under the auspices of the French Society of Gerontology and Geriatrics, a multidisciplinary group of experts, including geriatricians, neurologists, epidemiologists, psychiatrists, pharmacologists, and public health specialists developed consensus recommendations about care for patients with severe dementia. They defined 21 recommendations for general practitioners, long-term care physicians, and specialists, based on the knowledge currently available (2005). The aim of care at all stages is to mitigate the quality-of-life of patient, caregiver, and family insofar as possible, combining care and future planning until the end of life. Management, to take into account problems including nutritional status, behavior disorders, and ability (or inability) to perform activities of daily living, must be global, multidisciplinary, and coordinated and must optimize use of local medical and social resources. The group also stressed the importance of clinical research to improve knowledge of disease course and assess management strategies and recommended specific area for research.
Assuntos
Demência/diagnóstico , Demência/terapia , Idoso , Encéfalo/patologia , Cuidadores/psicologia , Continuidade da Assistência ao Paciente , Demência/epidemiologia , Demência/psicologia , Avaliação da Deficiência , Avaliação Geriátrica , Hospitalização , Humanos , Testes Neuropsicológicos , Direitos do PacienteRESUMO
Postmenopausal fractures are associated with low bone mass; however, the role of low peak bone mass in young adults in determining subsequent osteoporosis suggests that premenopausal fractures may also be relevant. We therefore sought to determine whether a self-reported previous history of premenopausal wrist and nonwrist fractures could also be associated with bone density and therefore be used to predict osteoporosis. We recruited 453 volunteer women with a median age of 64 years (range 50-83 years), with no metabolic bone disease, previous femoral neck fracture, or prevalent vertebral fracture. Bone density at the femoral neck (FN) and lumbar spine (LS) was measured using a Lunar DPX-L. As expected, the 319 women who did not report any fracture had a higher T score at LS (-0.93 +/- 1.44) than the 134 women who reported a previous fracture at any site and at any age (T score -1.60 +/- 1.21, p < 0.001). The findings for the FN were similar. Compared with fracture-free women, the women who reported a first wrist fracture before menopause now had a lower LS T score (-1.77 +/- 1.20, n = 15, p < 0.05), whereas those who reported a nonwrist fracture showed no significant decrease in their LS T score (-1.26 +/- 1.00, n = 36). When both wrist and nonwrist fractures had occurred after menopause, the T score was significantly lower. Twenty percent of the fracture-free women were osteoporosis patients. After adjusting for body weight, age, hormonal replacement therapy (HRT), and hip fracture in the family, the relative risk (RR) of osteoporosis for premenopausal wrist fractures was 2.7 (95% confidence interval 1.4-4.3) vs. 1.2 (0.7-2.4) for women with premenopausal nonwrist fractures. We conclude that self-reported premenopausal wrist fractures, but no other fractures occurring before menopause, are likely to be associated with osteoporosis at 65 years of age, and therefore constitute strong grounds for screening.
Assuntos
Densidade Óssea/fisiologia , Fraturas Ósseas/fisiopatologia , Osteoporose Pós-Menopausa/fisiopatologia , Pré-Menopausa/fisiologia , Traumatismos do Punho/fisiopatologia , Idoso , Idoso de 80 Anos ou mais , Análise de Variância , Intervalos de Confiança , Feminino , Humanos , Modelos Logísticos , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/diagnóstico , Fatores de RiscoRESUMO
The effect of age on the peripheral nervous system was investigated by clinical examination and neurophysiological studies in 59 subjects aged 60-103 years and 23 young subjects. A full laboratory screen for factors which, though clinically silent, may constitute risk factors (RFs) for peripheral neuropathy was also performed in the elderly subjects. Our findings show that the presence of RFs affects exceptionally the electrophysiological parameters in a statistically significant way. The age-dependent changes in nerve conduction parameters were well predicted by non-linear models. The simultaneous electromyographical study demonstrates the re-innervation capacity of the motor system.
Assuntos
Envelhecimento/fisiologia , Hipestesia/fisiopatologia , Nervos Periféricos/fisiopatologia , Reflexo Anormal/fisiologia , Reflexo de Estiramento/fisiologia , Vibração , Potenciais de Ação , Adulto , Idoso , Idoso de 80 Anos ou mais , Eletromiografia , Humanos , Pessoa de Meia-Idade , Condução Nervosa , Fatores de RiscoAssuntos
Envelhecimento/fisiologia , Doença de Alzheimer , Atividades Cotidianas , Idoso , Idoso de 80 Anos ou mais , Doença de Alzheimer/classificação , Doença de Alzheimer/epidemiologia , Doença de Alzheimer/fisiopatologia , Doença de Alzheimer/terapia , Efeitos Psicossociais da Doença , Feminino , Avaliação Geriátrica , Serviços de Saúde para Idosos , Humanos , Institucionalização , Masculino , Índice de Gravidade de DoençaRESUMO
Peripheral-type benzodiazepine binding sites on intact platelets from untreated chronic insomniac patients and those chronically treated with benzodiazepine hypnotics were investigated to evaluate their putative involvement in sleep pathology and the influence of treatment. There were 34 elderly subjects in the study, 14 controls (80.7 years) and 20 insomniac patients, of whom 7 were untreated (61.1 years) and 13 were treated (84.4 years). There was an equivalent number of peripheral-type benzodiazepine 3H-PK 11195 binding sites on platelets from untreated (7.61 pmol/mg protein) and treated insomniacs (6.39 pmol/mg protein) and on platelets from the controls (6.21 pmol/mg protein). However, there was a twofold reduction in the affinity of these sites in untreated (Kd = 8.02 nM) and treated (Kd = 7.40 nM) insomniacs compared to controls (3.79 nM). This difference raises the possibility that peripheral-type benzodiazepine sites are involved in abnormal sleep.
Assuntos
Receptores de GABA-A/metabolismo , Distúrbios do Início e da Manutenção do Sono/metabolismo , Adulto , Idoso , Idoso de 80 Anos ou mais , Plaquetas/metabolismo , Feminino , Humanos , Isoquinolinas/metabolismo , Masculino , Pessoa de Meia-IdadeRESUMO
During winter 75/76 (from February 1 to March 31) we got the opportunity to follow the incidence of an influenza epidemic that occurred in the geriatric hospital of Ivry. Its population was, on the average, 83 years old. 958 persons were involved in this study: 523 out of them had been vaccinated with Pasteur bivalent Mutagrip A + B vaccine. The epidemic had a double origin: it was due to a virus A/Victoria and to a virus B/Hong Kong. A significant difference was noted between the vaccinated group and the nonvaccinated one. Serological (CF and HI) and virological investigations (virus isolation) were performed on 110 subjects. The clinical course followed by the disease was mild for the vaccinated and severe for the nonvaccinated. Mortality rate was 0.19% in the former against 3.90% in the latter. It has been thus possible to observe an "immunological fence" since it appears that when 79% of a given unit has been vaccinated, influenza incidence has been as much as three times reduced.